Literature DB >> 16776452

Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001.

T H Holtz1, J Lancaster, K F Laserson, C D Wells, L Thorpe, K Weyer.   

Abstract

SETTING: Multidrug-resistant tuberculosis (MDR-TB) treatment centers in five provinces, South Africa.
OBJECTIVES: To estimate the mortality and evaluate risk factors associated with default from MDR-TB treatment.
DESIGN: Using registries and a standardized questionnaire, we conducted a case-control study among patients diagnosed and treated for MDR-TB. Cases were defined as patients who began MDR-TB treatment between 1 October 1999 and 30 September 2001 and defaulted from treatment for more than 2 months; controls were defined as patients who began MDR-TB treatment during the same time and were cured, completed or failed.
RESULTS: After initial identification and reclassification, 269 cases and 401 controls were confirmed eligible for interview. Further investigation revealed that 74 (27%) cases and 44 (10%) controls had died. Among 96 cases located who consented and were interviewed, 70% had defaulted after receiving at least 6 months of treatment. In a multivariate model, the strongest individual risk factors for default included reporting smoking marijuana or mandrax during treatment, and having an unsatisfactory opinion about the attitude of health care workers.
CONCLUSION: Mortality among MDR-TB defaulters was high. Interventions to reduce default from MDR-TB treatment should center on substance abuse treatment, patient education and support and improving provider-patient relationships.

Entities:  

Mesh:

Year:  2006        PMID: 16776452

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  41 in total

1.  Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis.

Authors:  Nathan Kapata; Martin P Grobusch; Gershom Chongwe; Pascalina Chanda-Kapata; William Ngosa; Mathias Tembo; Shebba Musonda; Patrick Katemangwe; Matthew Bates; Peter Mwaba; Alimuddin Zumla; Frank Cobelens
Journal:  Infection       Date:  2017-08-04       Impact factor: 3.553

2.  Correlates of Mandrax use and condom beliefs in preventing sexually transmitted infections among a cohort of South African prison inmates.

Authors:  Torrance T Stephens; Darius Gardner; Keena Jones; Sibusiso Sifunda; Ronald Braithwaite; Selina E Smith
Journal:  Int Health       Date:  2015-08-27       Impact factor: 2.473

3.  Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.

Authors:  Molly F Franke; Sasha C Appleton; Jaime Bayona; Fernando Arteaga; Eda Palacios; Karim Llaro; Sonya S Shin; Mercedes C Becerra; Megan B Murray; Carole D Mitnick
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

4.  Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Authors:  Medea Gegia; Iagor Kalandadze; Russel R Kempker; Matthew J Magee; Henry M Blumberg
Journal:  Int J Infect Dis       Date:  2012-03-17       Impact factor: 3.623

5.  High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.

Authors:  J C M Brust; N R Gandhi; H Carrara; G Osburn; N Padayatchi
Journal:  Int J Tuberc Lung Dis       Date:  2010-04       Impact factor: 2.373

6.  Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.

Authors:  V Balaji; Peter Daley; Alok Azad Anand; Thambu Sudarsanam; Joy Sarojini Michael; Rani Diana Sahni; Poorvi Chordia; Ige Abraham George; Kurien Thomas; Alka Ganesh; K R John; Dilip Mathai
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 7.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

8.  Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.

Authors:  Sanjay Basu; Jason R Andrews; Eric M Poolman; Neel R Gandhi; N Sarita Shah; Anthony Moll; Prashini Moodley; Alison P Galvani; Gerald H Friedland
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

9.  Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa.

Authors:  Kwonjune J Seung; David B Omatayo; Salmaan Keshavjee; Jennifer J Furin; Paul E Farmer; Hind Satti
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

10.  Underreported threat of multidrug-resistant tuberculosis in Africa.

Authors:  Yanis Ben Amor; Bennett Nemser; Angad Singh; Alyssa Sankin; Neil Schluger
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.